Spectrila

pegaspargase · medac GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Spectrila, covering 2023-11-20 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia [Phase 2]